Inventor profile of:

Laura Codarri Deak

City:

Au

Country:

Switzerland

Published Applications:

21

Last publication date:

2026-06-25

Top Assignees for applications by Laura Codarri Deak

The entities that hold a legal rights for patent applications filed by inventor Deak Laura Codarri:

Recent patent applications by Deak Laura Codarri

Laura Codarri Deak from Au, CH has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-06-25
US20260176377A1
Chemistry; metallurgy

AGONISTIC SPLIT ANTIBODIES

#2 | 2026-03-26
US20260085113A1
Chemistry; metallurgy

ALL-IN-ONE AGONISTIC ANTIBODIES

#3 | 2026-03-26
US20260083855A1
Human necessities

IMMUNOCONJUGATES

#4 | 2026-03-19
US20260077044A1
Human necessities

COMBINATION THERAPY EMPLOYING A PD1-LAG3 BISPECIFIC ANTIBODY AND AN HLA-G T CELL BISPECIFIC ANTIBODY

#5 | 2026-03-12
US20260070940A1
Chemistry; metallurgy

STABILIZED IMMUNOGLOBULIN DOMAINS

#6 | 2025-11-27
US20250361279A1
Chemistry; metallurgy

New Interleukin-7 Immunoconjugates

#7 | 2025-07-03
US20250215103A1
Chemistry; metallurgy

BISPECIFIC ANTIBODIES AND METHODS OF USE

#8 | 2025-03-06
US20250073308A1
Human necessities

Immunoconjugates

#9 | 2024-12-26
US20240425561A1
Chemistry; metallurgy

NEW INTERLEUKIN-7 IMMUNOCONJUGATES

#10 | 2024-09-05
US20240294642A1
Chemistry; metallurgy

ANTI-PD1 ANTIBODIES AND METHODS OF USE

#11 | 2024-08-15
US20240269277A1
Human necessities

ALTERNATIVE PD1-IL7V IMMUNOCONJUGATES FOR THE TREATMENT OF CANCER

#12 | 2024-08-08
US20240262913A1
Chemistry; metallurgy

COMBINATION THERAPY OF PD-1-TARGETED IL-2 VARIANT IMMUNOCONJUGATE AND ANTI-TYRP1/ANTI-CD3 BISPECIFIC ANTIBODIES

#13 | 2024-03-21
US20240092856A1
Chemistry; metallurgy

COMBINATION THERAPY OF PD-1-TARGETED IL-2 VARIANT IMMUNOCONJUGATES AND FAP/4-1BB BINDING MOLECULES

#14 | 2024-02-08
US20240043535A1
Chemistry; metallurgy

IMMUNE ACTIVATING Fc DOMAIN BINDING MOLECULES

#15 | 2024-01-04
US20240002546A1
Chemistry; metallurgy

COMBINATION THERAPY EMPLOYING A PD1-LAG3 BISPECIFIC ANTIBODY AND A CD20 T CELL BISPECIFIC ANTIBODY

#16 | 2023-06-22
US20230192795A1
Chemistry; metallurgy

IMMUNOCONJUGATES

#17 | 2023-06-15
US20230183349A1
Chemistry; metallurgy

ANTI-PD1 ANTIBODIES AND METHODS OF USE

#18 | 2023-06-15
US20230181712A1
Human necessities

COMBINATION THERAPY WITH MODIFIED PBMCS AND AN IMMUNOCONJUGATE

#19 | 2023-05-11
US20230143310A1
Chemistry; metallurgy

ANTI-PD1 ANTIBODIES AND METHODS OF USE

#20 | 2019-12-19
US20190382489A1
Chemistry; metallurgy

ANTI-PD1 ANTIBODIES AND METHODS OF USE

#21 | 2017-08-31
US20170247454A1
Chemistry; metallurgy

ANTI-PD1 ANTIBODIES AND METHODS OF USE

InventorID:

1970631 ⎘